Prevalence of genital Chlamydia trachomatis infection among young men and women in Spain

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Fernández Benítez, Carlos ^a   Mejuto López, Patricia ^b   Otero Guerra, Luis ^c   Margolles Martins, Mario J ^d   Suárez Leiva, Pilar ^b   Vazquez, Fernando ^b,e  

^a Centro Salud de Laviana   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c HOSPITAL DE CABUEÑES   (Spain)

^d Instituto Murciano de Investigación Biosanitaria Arrixaca   (Spain)

^e UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

Chlamydia infections; Mass screening; Prevalence; Sexually transmitted diseases

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIUM IDENTIFICATION; CHLAMYDIA TRACHOMATIS; CHLAMYDIAL URETHRITIS; CONDOM; CONTRACEPTION; DISEASE SURVEILLANCE; FEMALE; GENOTYPE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SEXUAL BEHAVIOR; SPAIN; URINALYSIS;

EID: 84884486712     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-388     Document Type: Article

References (18)

1. European Centre for Disease Prevention and Control Sexually transmitted infections in Europe, 1990-2009 2011, Stockholm: ECDC, http://ecdc.europa.eu/en/publications/Publications/110526_SUR_STI_in_Europe_1990-2009.pdf, 3490824, 22853319, European Centre for Disease Prevention and Control.
2. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010, 201(Suppl 2):S134-S155.
3. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999, 7:3-17.
4. Preventive Services US, . Task Force Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2007, 147:128-134. Task Force.
5. Cacho J, Sanz F, Blanco M. Silent disease caused by Chlamydia trachomatis: the urgent need for it to be detected and treated in women. Enferm Infecc Microbiol Clin 2001, 19:419-421. 10.1016/S0213-005X(01)72684-5, 11709118.
6. Shafer MA, Tebb KP, Pantell RH, Wibbelsman CJ, Neuhaus JM, Tipton AC, Kunin SB, Ko TH, Schweppe DM, Bergman DA. Effect of a clinical practice improvement intervention on Chlamydial screening among adolescent girls. JAMA 2002, 288:2846-2852. 10.1001/jama.288.22.2846, 12472326.
7. Lysén M, Osterlund A, Rubin CJ, Persson T, Persson I, Herrmann B. Characterization of OmpA genotypes by sequence analysis of DNA from all detected cases of Chlamydia trachomatis infections during 1 year of contact tracing in a Swedish county. J Clin Microbiol 2004, 42:1641-1647. 10.1128/JCM.42.4.1641-1647.2004, 387550, 15071019.
8. Honey E, Augood C, Templeton A, Russell I, Paavonen J, Mårdh PA, Stary A, Stray-Pedersen B. Cost effectiveness for screening for Chlamydia trachomatis: a review of published studies. Sex Transm Infect 2002, 78:406-412. 10.1136/sti.78.6.406, 1758346, 12473799.
9. Corbeto EL, Lugo R, Martró E, Falguera G, Ros R, Avecilla A, Coll C, Saludes V, Casabona J. Prevalence and determining factors of acquiring C. trachomatis infection among adolescents and young adults in Catalonia. Enferm Infecc Microbiol Clin 2011, 29:96-101. 10.1016/j.eimc.2010.08.011, 21324559.
10. Nogales MC, Castro C, Ramírez M, Pueyo I, Pérez L, Jarana R, Martín E. Diagnosis of Chlamydia trachomatis infection in a clinic for sexually transmitted disease: evaluation of cervical, urethral and rectal swab samples by polymerase chain reaction. Enferm Infecc Microbiol Clin 2007, 25:11-15. 10.1157/13096747, 17261241.
11. Folch C, Esteve A, Sanclemente C, Martró E, Lugo R, Molinos S, Gonzalez V, Ausina V, Casabona J. Prevalence of human immunodeficiency virus, Chlamydia trachomatis, and Neisseria gonorrhoeae and risk factors for sexually transmitted infections among immigrant female sex workers in Catalonia, Spain. Sex Transm Dis 2008, 35:178-183. 10.1097/OLQ.0b013e31815a848d, 18046265.
12. Goulet V, de Barbeyrac B, Raherison S, Prudhomme M, Semaille C, Warszawski J, . CSF group Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France. Sex Transm Infec 2010, 86:263-270. CSF group.
13. Fenton KA, Korovessis C, Johnson AM, McCadden A, McManus S, Wellings K, Mercer CH, Carder C, Copas AJ, Nanchahal K, Macdowall W, Ridgway G, Field J, Erens B. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 2001, 358:1851-1854. 10.1016/S0140-6736(01)06886-6, 11741624.
14. Klavs I, Rodriguez LC, Wellings K, Kese D, Hayes R. Prevalence of genital Chlamydia trachomatis infection in the general population of Slovenia: serious gaps in control. Sex Transm Infect 2004, 80:121-123. 10.1136/sti.2003.005900, 1744809, 15054174.
15. Centers for Disease Control and Prevention CDC Grand Rounds: Chlamydia Prevention: challenges and strategies for reducing disease burden and sequelae. MMWR 2011, 60:370-373. Centers for Disease Control and Prevention.
16. Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, Cohen MS, Harris KM, Udry JR. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004, 291:2229-2236. 10.1001/jama.291.18.2229, 15138245.
17. Kretzschmar M, Satterwhite C, Leichliter J, Berman S. Effects of screening and partner notification on Chlamydia positivity in the United States: a modeling study. Sex Transm Dis 2012, 39:325-331. 10.1097/OLQ.0b013e31824e52c2, 22504590.
18. Johnson TP, Wislar JS. Response rates and nonresponse errors in surveys. JAMA 2012, 307:1805-1806. 10.1001/jama.2012.3532, 22550194.